Primary cell culture market size worth $8B by 2028

The global primary cell culture market size is expected to reach USD 8.0 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.6% from 2021 to 2028. The market growth is owing to several factors such as advancement in genetic engineering, rising demand for regenerative medicines, and robust funding for cellular therapies development.

In addition, the growing focus on functional biology can be further attributed to the market growth. Several R&D investments for the development of novel solutions have increased the demand for culture medium. For instance, in April 2020, Sumitomo Chemical invested USD 30 million in Conagen a U.S.-based company. The investment was aimed at strengthening its alliance and developing high functional products as well as processes using synthetic biology.

Moreover, the ongoing COVID-19 pandemic has provided an opportunity for researchers to study and understand the new variants of the virus with the application of primary cell culture. The large pool of human cells from various genetic backgrounds and varied health conditions facilitated researchers to conduct experiments for thorough results. Various institutions have shown their support and interest in scientific research to match specialized cell culture media. Grand View Research